PLEIOTROPIC EFFECTS OF STATINS
Top Cited Papers
- 22 September 2005
- journal article
- review article
- Published by Annual Reviews in Annual Review of Pharmacology and Toxicology
- Vol. 45 (1) , 89-118
- https://doi.org/10.1146/annurev.pharmtox.45.120403.095748
Abstract
▪ Abstract Statins are potent inhibitors of cholesterol biosynthesis. In clinical trials, statins are beneficial in the primary and secondary prevention of coronary heart disease. However, the overall benefits observed with statins appear to be greater than what might be expected from changes in lipid levels alone, suggesting effects beyond cholesterol lowering. Indeed, recent studies indicate that some of the cholesterol-independent or “pleiotropic” effects of statins involve improving endothelial function, enhancing the stability of atherosclerotic plaques, decreasing oxidative stress and inflammation, and inhibiting the thrombogenic response. Furthermore, statins have beneficial extrahepatic effects on the immune system, CNS, and bone. Many of these pleiotropic effects are mediated by inhibition of isoprenoids, which serve as lipid attachments for intracellular signaling molecules. In particular, inhibition of small GTP-binding proteins, Rho, Ras, and Rac, whose proper membrane localization and functio...Keywords
This publication has 181 references indexed in Scilit:
- The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune diseaseNature, 2002
- Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.Journal of Clinical Investigation, 1998
- Nitric Oxide Protects Against Leukocyte-Endothelium Interactions in the Early Stages of HypercholesterolemiaArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Platelet Cytosolic Ca 2+ and Membrane Dynamics in Patients With Primary HypercholesterolemiaArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Inhibition of Thromboxane Biosynthesis and Platelet Function by Simvastatin in Type IIa HypercholesterolemiaArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- The acute phase responseImmunology Today, 1994
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Changes in Risk Factors and the Decline in Mortality from Cardiovascular DiseaseNew England Journal of Medicine, 1990
- Regulation of the mevalonate pathwayNature, 1990